KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.75 $7.64 Friday, 26th Apr 2024 FATE stock ended at $3.80. This is 1.81% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $3.75 to a day high of $3.95.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Feb 15, 2023 $6.28 $6.43 $6.18 $6.34 2 142 660
Feb 14, 2023 $6.35 $6.53 $6.18 $6.32 2 583 317
Feb 13, 2023 $6.23 $6.44 $6.11 $6.39 2 018 683
Feb 10, 2023 $6.13 $6.28 $6.03 $6.22 1 576 946
Feb 09, 2023 $6.50 $6.62 $6.09 $6.20 1 829 299
Feb 08, 2023 $6.84 $6.95 $6.38 $6.46 2 751 164
Feb 07, 2023 $6.78 $7.08 $6.59 $6.84 1 933 612
Feb 06, 2023 $6.80 $6.88 $6.60 $6.77 1 578 122
Feb 03, 2023 $6.58 $6.95 $6.40 $6.87 3 283 017
Feb 02, 2023 $6.56 $7.02 $6.53 $6.83 3 217 526
Feb 01, 2023 $5.94 $6.40 $5.86 $6.37 2 426 525
Jan 31, 2023 $5.80 $6.32 $5.75 $5.96 3 265 591
Jan 30, 2023 $5.86 $5.92 $5.66 $5.73 2 859 160
Jan 27, 2023 $5.29 $6.01 $5.25 $5.92 2 768 809
Jan 26, 2023 $5.48 $5.49 $5.16 $5.30 1 946 675
Jan 25, 2023 $5.34 $5.45 $5.17 $5.40 2 599 180
Jan 24, 2023 $5.42 $5.60 $5.35 $5.43 2 643 405
Jan 23, 2023 $5.59 $5.68 $5.33 $5.55 3 929 416
Jan 20, 2023 $5.78 $5.80 $5.45 $5.47 3 041 388
Jan 19, 2023 $5.77 $5.88 $5.59 $5.65 2 785 538
Jan 18, 2023 $5.78 $5.91 $5.60 $5.81 3 120 214
Jan 17, 2023 $5.73 $5.86 $5.57 $5.72 4 293 339
Jan 13, 2023 $5.83 $5.90 $5.38 $5.40 3 002 631
Jan 12, 2023 $5.73 $5.87 $5.35 $5.86 2 612 842
Jan 11, 2023 $5.49 $5.78 $5.32 $5.72 3 940 100
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT